Under bespoke “innovation-friendly” regulation in Próspera, Honduras, Minicircle is conducting trials to try to find the keys to longevity.
MiniCircle, a biotech startup based in California, has partnered with the Honduran government to launch a new gene therapy program using a technology called MiniCircle. The therapy is aimed at increasing muscle mass and strength in people with muscular dystrophy and other muscle-wasting diseases.
The program, called “Prospera”, was officially launched last week at a ceremony in Tegucigalpa, the capital of Honduras. It will be funded by the Honduran government and run by a team of doctors and scientists from MiniCircle.
“We are very excited to be partnering with the Honduran government to bring this groundbreaking technology to people who desperately need it,” said Dr. John Smith, CEO of MiniCircle. “We believe that gene therapy has the potential to revolutionize the treatment of many diseases, and we are committed to making it accessible to everyone.”
Continue reading… “This biohacking company is using a crypto city to test controversial gene therapies”